Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Study of the Efficacy of High Dose Dexamethasone Versus High Dose Dexamethasone in Combination With Rituximab (MabThera®)in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)

NCT00909077 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT00909077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00909077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Study of the Efficacy of High Dose Dexamethasone Versus High Dose Dexamethasone in Combination With Rituximab (MabThera®)in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
August 1, 2017
Enrollment
155 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic thrombocytopenic purpura